{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:12:57Z","timestamp":1788250377055,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eplepsyres.2025.107614","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T02:44:39Z","timestamp":1750733079000},"page":"107614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Blood-brain barrier impairment as an early marker of neurodegeneration in late-onset epilepsy of unknown origin"],"prefix":"10.1016","volume":"217","author":[{"given":"Silvia","family":"Maio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Izzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2025.107614_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/epi4.12744","article-title":"Assessment of tau phosphorylation and \u03b2-amyloid pathology in human drug-resistant epilepsy","volume":"8","author":"Aroor","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000493484","article-title":"Aging and the epidemiology of epilepsy","author":"Beghi","year":"2018","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/ars.2011.3895","article-title":"Amyloid beta induces oxidative stress-mediated blood\u2013brain barrier changes in capillary amyloid angiopathy","volume":"15","author":"Carrano","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","article-title":"The molecular constituents of the blood-brain barrier","volume":"38","author":"Chow","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neurobiolaging.2016.08.025","article-title":"Epilepsy, amyloid-\u03b2, and D1 dopamine receptors: a possible pathogenetic link?","volume":"48","author":"Costa","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2018.09.006","article-title":"Alzheimer\u2019s disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology","volume":"73","author":"Costa","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib7","article-title":"In-vivo evidence for increased tau deposition in temporal lobe epilepsy","author":"Cruces","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jalz.2013.12.023","article-title":"The cerebrospinal fluid \u201calzheimer profile\u201d: Easily said, but what does it mean?","volume":"10","author":"Duits","year":"2014","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib9","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab. Off. J. Int. Soc. Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib10","doi-asserted-by":"crossref","first-page":"5384","DOI":"10.1111\/ejn.15734","article-title":"Cognitive functioning, cerebrospinal fluid Alzheimer\u2019s disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: a prospective study","volume":"56","author":"Fernandes","year":"2022","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib11","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1528-1157.1993.tb02586.x","article-title":"Incidence of epilepsy and unprovoked seizures in rochester, minnesota: 1935\u20131984","volume":"34","author":"Hauser","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib13","unstructured":"IBM, 2020. SPSS - Statistical Package for Social Sciences."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"Janelidze","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106592","article-title":"Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: a 12-month follow-up study","volume":"101","author":"Liguori","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib16","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JAD-191124","article-title":"Sleep-wake cycle in alzheimer\u2019s disease is associated with tau pathology and orexin dysregulation","volume":"74","author":"Liguori","year":"2020","journal-title":"J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib17","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/alz.12104","article-title":"Tau and apolipoprotein E modulate cerebrovascular tight junction integrity independent of cerebral amyloid angiopathy in Alzheimer\u2019s disease","volume":"16","author":"Liu","year":"2020","journal-title":"Alzheimer\u2019S. Dement"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib19","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","article-title":"Amyloid-\u03b2(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease","volume":"56","author":"Mulder","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib21","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib22","first-page":"79","article-title":"Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics","volume":"21","author":"Reiber","year":"2003","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41582-021-00505-9","article-title":"Amyloid-\u03b2: a potential link between epilepsy and cognitive decline","volume":"17","author":"Romoli","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.expneurol.2009.07.028","article-title":"A\u03b21-42 detection in CSF of Alzheimer\u2019s disease is influenced by temperature: indication of reversible A\u03b21-42 aggregation?","volume":"223","author":"Sancesario","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE Classification of the epilepsies position paper of the ILAE commission for classification and terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib26","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1111\/epi.17086","article-title":"Low prevalence of amyloid and tau pathology in drug-resistant temporal lobe epilepsy","volume":"62","author":"Silva","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.491","article-title":"Adiponectin controls the apoptosis and the expression of tight junction proteins in brain endothelial cells through AdipoR1 under beta amyloid toxicity","volume":"8","author":"Song","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2018.09.006","article-title":"Decline in Sirtuin-1 expression and activity plays a critical role in blood-brain barrier permeability in aging","volume":"126","author":"Stamatovic","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: From physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib31","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/brain\/aww187","article-title":"Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: a study of temporal lobe resections","volume":"139","author":"Tai","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib32","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/brain\/awr209","article-title":"Neurofibrillary tangle pathology and braak staging in chronic epilepsy in relation to traumatic brain injury and hippocampal sclerosis: a post-mortem study","volume":"134","author":"Thom","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scand. J. Clin. Lab. Invest"},{"key":"10.1016\/j.eplepsyres.2025.107614_bib34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107614_bib35","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125001159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125001159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T23:35:47Z","timestamp":1760657747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125001159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":35,"alternative-id":["S0920121125001159"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107614","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-brain barrier impairment as an early marker of neurodegeneration in late-onset epilepsy of unknown origin","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107614"}}